Uperio® Tablets (Sacubitril + Valsartan) are a prescription medication indicated for the management of heart failure with reduced ejection fraction (HFrEF) in adults. Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB), work together to reduce strain on the heart by relaxing blood vessels, decreasing blood pressure, and improving heart function. Uperio® has been shown to reduce the risk of cardiovascular death and hospitalization in patients with heart failure when used as part of a comprehensive treatment plan. This medication should be used under the guidance of a qualified healthcare professional, with regular monitoring of blood pressure, kidney function, and electrolytes.
